What is the most likely cause of red-brown macular lesions on the palms and soles in a person with psoriasis secondary to syphilis, atypical psoriasis, or dermatitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Most Likely Diagnosis: Secondary Syphilis

In a person with psoriasis presenting with red-brown macular lesions on palms and soles, secondary syphilis is the most likely diagnosis and must be ruled out immediately with serologic testing. 1, 2

Critical Diagnostic Reasoning

Why Secondary Syphilis is Most Likely

  • Red-brown macules on palms and soles are the hallmark presentation of secondary syphilis, with symmetric palmoplantar involvement being highly characteristic 1, 3
  • The American Academy of Dermatology emphasizes that acute onset over weeks is inconsistent with psoriasis, which follows a chronic, stable course or gradual progression 1, 2
  • Palmoplantar psoriasis presents with hyperkeratotic, fissured plaques, NOT red-brown macules 2
  • The CDC guidelines highlight that copper-colored macules with symmetric distribution strongly favor syphilis over other dermatoses 2

Why Other Diagnoses are Less Likely

  • Atypical psoriasis: While psoriasiform syphilis exists and can mimic psoriasis 4, 5, true palmoplantar psoriasis lacks the red-brown macular morphology and acute onset pattern 2
  • Dermatitis: Atopic or seborrheic dermatitis do not characteristically involve palms and soles with this specific morphology 2
  • The presence of pre-existing psoriasis does not exclude secondary syphilis; in fact, syphilis is known as "the great masquerader" and can coexist with or mimic other conditions 4

Immediate Diagnostic Workup

The American Academy of Dermatology recommends immediate serologic testing for syphilis in any patient with symmetric palmoplantar red-brown macules 1:

  • RPR/VDRL (non-treponemal test) 1, 2
  • Treponemal-specific testing (FTA-ABS or TP-PA) to confirm diagnosis 2
  • HIV screening is mandatory, as syphilis and HIV frequently coexist 1, 2

Treatment Implications

If syphilis is confirmed, benzathine penicillin G 2.4 million units IM as a single dose is the standard treatment for secondary syphilis per CDC guidelines 1:

  • Partner notification and treatment is mandatory 1, 2
  • Follow-up serology is required to confirm treatment response 1
  • Avoid treating presumptively as psoriasis with immunosuppressive agents before excluding syphilis 4

Critical Clinical Pitfalls

  • Never initiate immunosuppressive therapy for presumed psoriasis without first excluding syphilis in patients with palmoplantar involvement 4, 5
  • The coexistence of known psoriasis does not rule out secondary syphilis; both conditions can occur simultaneously 4
  • Dermoscopy can help differentiate palmar syphiloderm from palmar papular psoriasis when clinical distinction is difficult 6
  • Histopathology may show psoriasiform features in secondary syphilis, making clinical correlation essential 4, 5

References

Guideline

Diagnosis and Management of Secondary Syphilis and Palmoplantar Psoriasis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Secondary Syphilis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Vasculitis in a case of rupioid syphilis in HIV.

Proceedings (Baylor University. Medical Center), 2022

Research

Psoriasiform syphilis: A challenge.

Dermatology reports, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.